JP2021527051A5 - - Google Patents
Info
- Publication number
- JP2021527051A5 JP2021527051A5 JP2020567845A JP2020567845A JP2021527051A5 JP 2021527051 A5 JP2021527051 A5 JP 2021527051A5 JP 2020567845 A JP2020567845 A JP 2020567845A JP 2020567845 A JP2020567845 A JP 2020567845A JP 2021527051 A5 JP2021527051 A5 JP 2021527051A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- och
- nhc
- nhch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862680891P | 2018-06-05 | 2018-06-05 | |
| US62/680,891 | 2018-06-05 | ||
| US201962831006P | 2019-04-08 | 2019-04-08 | |
| US62/831,006 | 2019-04-08 | ||
| PCT/US2019/035462 WO2019236631A1 (en) | 2018-06-05 | 2019-06-04 | Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527051A JP2021527051A (ja) | 2021-10-11 |
| JP2021527051A5 true JP2021527051A5 (https=) | 2022-06-27 |
Family
ID=67185700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567845A Pending JP2021527051A (ja) | 2018-06-05 | 2019-06-04 | ピラゾロ−ピリミジン−アミノ−シクロアルキル化合物及びその治療的使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11046699B2 (https=) |
| EP (1) | EP3802544A1 (https=) |
| JP (1) | JP2021527051A (https=) |
| TW (1) | TW202016112A (https=) |
| WO (1) | WO2019236631A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111499644B (zh) * | 2020-04-24 | 2021-07-20 | 苏州大学 | 咪唑并[1,5-a]喹唑啉-5(4H)-酮类衍生物及其制备方法和用途 |
| GB202008749D0 (en) | 2020-06-09 | 2020-07-22 | Ip2Ipo Innovations Ltd | Novel compounds |
| US11767320B2 (en) | 2020-10-02 | 2023-09-26 | Incyte Corporation | Bicyclic dione compounds as inhibitors of KRAS |
| CN114516828A (zh) * | 2020-11-19 | 2022-05-20 | 江苏威奇达药业有限公司 | 一种提高负氮杂提取率的提取工艺 |
| US20250000859A1 (en) * | 2021-08-25 | 2025-01-02 | Alesta Therapeutics BV | Use of gcn2 inhibitors in treating cancer |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
| WO2023110936A1 (en) | 2021-12-14 | 2023-06-22 | Netherlands Translational Research Center Holding B.V | Reversible macrocyclic kinase inhibitors |
| KR20240157639A (ko) | 2021-12-14 | 2024-11-01 | 크로스파이어 온콜로지 홀딩 비.브이. | 거대고리 btk 억제제 |
| WO2023198114A1 (zh) * | 2022-04-13 | 2023-10-19 | 杭州邦顺制药有限公司 | Alk2激酶抑制剂 |
| WO2023205463A1 (en) | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds for the treatment of pain |
| WO2024126617A1 (en) | 2022-12-14 | 2024-06-20 | Crossfire Oncology Holding B.V. | Bifunctional compounds for degrading kinases via ubiquitin proteosome pathway |
| WO2024238570A1 (en) * | 2023-05-15 | 2024-11-21 | Aleksia Therapeutics, Inc. | Cdk2 inhibitor pyrazolopyrimidine compounds |
| CN117756677B (zh) * | 2023-12-21 | 2025-09-30 | 上海馨远医药科技有限公司 | 一种手性反式-n-boc-1-氨基环戊烷-3-甲酸的制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| DE69720965T2 (de) | 1996-02-13 | 2004-02-05 | Astrazeneca Ab | Chinazolinderivate und deren verwendung als vegf hemmer |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| AU2001258628A1 (en) | 2000-05-31 | 2001-12-11 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| MXPA02012903A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como inhibidores de angiogenesis. |
| MXPA02012905A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como agentes de dano vascular.. |
| WO2003029209A2 (en) * | 2001-10-02 | 2003-04-10 | Smithkline Beecham Corporation | Chemical compounds |
| CA2676665A1 (en) | 2007-01-30 | 2008-08-07 | Biogen Idec Ma Inc. | Modulators of mitotic kinases |
| US20130345268A1 (en) | 2009-02-13 | 2013-12-26 | The Trustees Of Dartmouth College | Methods and Compositions for the Treatment of RAS Associated Disorders |
| US8362023B2 (en) * | 2011-01-19 | 2013-01-29 | Hoffmann-La Roche Inc. | Pyrazolo pyrimidines |
| AU2014224975B2 (en) * | 2013-03-05 | 2017-09-14 | Merck Patent Gmbh | Triazolo(4,5-d)pyrimidine derivatives for the treatment of diseases such as cancer |
| EP2964648B1 (en) | 2013-03-05 | 2016-11-16 | Merck Patent GmbH | 9-(aryl or heteroaryl)-2-(pyrazolyl, pyrrolidinyl or cyclopentyl)aminopurine derivatives as anticancer agents |
-
2019
- 2019-06-04 EP EP19736849.1A patent/EP3802544A1/en not_active Withdrawn
- 2019-06-04 US US16/431,504 patent/US11046699B2/en active Active
- 2019-06-04 JP JP2020567845A patent/JP2021527051A/ja active Pending
- 2019-06-04 WO PCT/US2019/035462 patent/WO2019236631A1/en not_active Ceased
- 2019-06-05 TW TW108119522A patent/TW202016112A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527051A5 (https=) | ||
| JP2007501859A5 (https=) | ||
| JP2018519357A5 (https=) | ||
| JP2016526558A5 (https=) | ||
| RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
| JP2021514001A5 (https=) | ||
| JP2020169171A5 (https=) | ||
| RU2007109870A (ru) | 2,4-ди(аминофенил)пиримидины в качестве ингибиторов plk-киназ | |
| RU2001132635A (ru) | Производные пиперидина, применимые в качестве антагонистов сс R5 | |
| HRP20250099T1 (hr) | Agonisti receptora glp-1 i njihova upotreba | |
| JP2020500182A5 (https=) | ||
| RU2010111551A (ru) | Замещенные индольные производные и способы их применения | |
| RU2001132632A (ru) | Производные пиперазина, применимые в качестве антагонистов CCR5 | |
| JP2004516314A5 (https=) | ||
| RU2003133448A (ru) | 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора | |
| JP2009536660A5 (https=) | ||
| JP2017506250A5 (https=) | ||
| RU2018118216A (ru) | Соединения пуринона в качестве ингибиторов киназ | |
| HRP20160046T1 (hr) | Poboljšana citotoksiäśna sredstva koja sadrže nove majtanzinoide | |
| JP2012510523A5 (https=) | ||
| AR120652A1 (es) | Antagonistas de sstr5 | |
| JP2008505117A5 (https=) | ||
| RU2010103160A (ru) | ПРОИЗВОДНЫЕ 2-[(2-{ФЕНИЛАМИНО}-1Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)АМИНО]БЕНЗАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ IGF-1R ДЛЯ ЛЕЧЕНИЯ РАКА | |
| AR032569A1 (es) | Ligandos del receptor de canabinoide | |
| JP2021530559A5 (https=) |